Active, Not Recruiting
Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE
NCT06015230
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
- Locations
-
- Peking union Medical Hosipital Beijing, Beijing Municipality, China